← Back to headlines
Caris Life Sciences Reports Q4 Earnings and Revenue Beat
Caris Life Sciences, Inc. announced GAAP EPS of $0.28, beating estimates by $0.18, and revenue of $292.2 million, surpassing forecasts by $11.3 million.
26 Feb, 21:48 — 26 Feb, 21:48
ℹOnly 1 source covers this story
